GA

Gain Therapeutics IncNASDAQ GANX Stock Report

Last reporting period 31 Dec, 2023

Updated 23 Dec, 2024

Last price

Market cap $B

0.041

Micro

Exchange

XNAS - Nasdaq

View Section: Eyestock Rating

Gain Fair Value

GA

GANX stock is not valued by Eyestock.

The last 12 months ended with a loss, and this does not allow us to estimate the value of the company according to eyestock model

Discover Undervalued Companies


Gain Valuation

Current GANX share ticker price is 1.57 USD.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Min value

Max value

24.12.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

Gain Therapeutics Inc price metrics

-40.82

Annual return (geometric mean)

77.7

Risk (standard deviation) of returns

β

0.21

Beta (volatility compared to market)

It means that GANX stock is less volatile than the broader market
View Section: Profitability